ArticleMedical oncology (Northwood, London, England)2024

Unveiling the potency of FDA-approved oxidopamine HBr for cervical cancer regulation and replication proteins.

Nawal Helmi et al.PubMed ↗Publisher ↗

No numbers read from the abstract.